Get the Stockscreener App
149.31
0.30%
-0.45
Davita Inc stock is traded at $149.31, with a volume of 2.29M.
It is down -0.30% in the last 24 hours and down -0.94% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$149.76
Open:
$148.87
24h Volume:
2.29M
Relative Volume:
2.15
Market Cap:
$9.98B
Revenue:
$13.64B
Net Income/Loss:
$1.05B
P/E Ratio:
15.63
EPS:
9.555
Net Cash Flow:
$1.31B
1W Performance:
-0.94%
1M Performance:
-0.94%
6M Performance:
+14.71%
1Y Performance:
+0.20%
1-Day Range:
$148.87
$152.49
1-Week Range:
$147.76
$152.49
52-Week Range:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
149.31 | 9.98B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
493.88 | 110.42B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
200.35 | 17.42B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
200.08 | 11.63B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
185.82 | 11.35B | 17.36B | 1.51B | 849.25M | 23.15 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Hedge Fund Moves: Can DaVita Inc continue delivering strong returnsGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Truist Lowers PT on DaVita Inc. (DVA), Keeps a Hold Rating - MSN
DaVita Stock: Is DVA Outperforming the Health Care Sector? - Barchart
DaVita Inc Stock (ISIN: US23804L1035) Gains on Value-Based Care Progress Amid Institutional Selling - AD HOC NEWS
DaVita’s Strong Operations Confront Debt Warning And Insider Selling Signals - Yahoo Finance
DaVita reports progress in value-based kidney care programs - Investing.com
DaVita's kidney care program delivered $200M in savings as quality improved - Stock Titan
Chart Watch: Will DaVita Inc stock benefit from M A2026 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare - Zacks Investment Research
DaVita getting closer to key technical benchmark - MSN
Zacks Industry Outlook Features Quest Diagnostics, DaVita, Option Care Health, and Addus HomeCare - Bitget
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita tops chart as the only large-cap healthcare services name rated strong buy - MSN
DaVita (DVA) Backs R1 Therapeutics with Major Investment - GuruFocus
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease - GlobeNewswire Inc.
Zacks.com featured highlights include Strategic Education, Seanergy Maritime Holdings, DaVita and FirstEnergy - Yahoo Finance
Delta Global Management LP Buys New Holdings in DaVita Inc. $DVA - MarketBeat
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
DaVita Inc Stock (ISIN: US23804L1035) Faces Headwinds Amid Dialysis Demand Shifts and Regulatory Scr - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. Trade Ideas — LS:897914 - TradingView
DaVita Stock Sits at $151 With Analysts Pointing to a $190 High Target - TIKR.com
DaVita Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
DaVita Inc. $DVA Shares Acquired by Doma Perpetual Capital Management LLC - MarketBeat
Aquatic Capital Management Boosts Stake in DaVita - National Today
Aquatic Capital Management LLC Acquires 40,333 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Berkshire Hathaway Inc - MarketBeat
Is DaVita (DVA) Pricing Reflect Its Strong Multi‑Year Share Performance And Cash Flow Outlook - simplywall.st
DVA (DaVita) Graham Number : $N/A (As of Dec. 2025) - GuruFocus
DaVita (DVA) and Jazz Pharmaceuticals (JAZZ) Lead with Strong Bu - GuruFocus
DaVita Inc Stock (ISIN: US23804L1035) Gains Momentum on Institutional Buying and Strong Guidance - AD HOC NEWS
Jim Cramer on DaVita: "Haven’t seen that stock do that well in this long" - MSN
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
DaVita, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Te Ahumairangi Investment Management Ltd Has $9.10 Million Position in DaVita Inc. $DVA - MarketBeat
DaVita, Inc. Experiences Revision in Stock Evaluation Amidst Market Dynamics - Markets Mojo
A Look At DaVita (DVA) Valuation As Analyst Concerns Clash With Bullish Ratings - simplywall.st
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DAVITA INC (NYSE:DVA) Emerges as a Technical Breakout Candidate - ChartMill
Ohio Hospital Defeats DaVita's Dialysis Discrimination Suit - Law360
Are Investors Undervaluing DaVita (DVA) Right Now? - Yahoo Finance
DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range - MSN
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship - CSRwire
Dimensional Fund Advisors LP Grows Holdings in DaVita Inc. $DVA - MarketBeat
WINTON GROUP Ltd Invests $5.76 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. (DVA) Receives Top Rating Amid Healthcare Sector Pre - GuruFocus
How DaVita’s Buybacks-Driven Earnings Outlook Despite Falling Volumes Will Impact DaVita (DVA) Investors - simplywall.st
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy (DVA:NYSE) - Seeking Alpha
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract - MSN
40,785 Shares in DaVita Inc. $DVA Bought by Munich Reinsurance Co Stock Corp in Munich - MarketBeat
DaVita Rethinks Kidney Care As Volumes Decline And Elara Stake Grows - Yahoo Finance
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):